Skip to Main Content

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember, there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Meanwhile, the time has come to get cracking. So here are a few items of interest. Hope your day goes well. And if you see the Great Pumpkin, please send our regards …

Allergan (AGN) expressed disappointment with early offers from potential buyers for business units it has been trying to sell, and its shares fell more than 7 percent, Reuters writes. The drug maker has been shopping its women’s health and infectious disease businesses since May, following a strategic review of the company undertaken in an effort to reverse a steep slide in its share price. But on a call with analysts to discuss third-quarter results, chief executive officer Brent Saunders said early buyer interest for the units was below the price he believes they are worth.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!